Pharmaniaga touting stability to potential investors

Reading Time: 1 minute

Executives at Malaysian pharmaceutical company Pharmaniaga say that the company is set to make up 10% of its majority stakeholder’s business in 2011, and 15% of business within the next five years.  Boustead Group owns approximately 97% of the company, but is looking to reduce its contribution to about 75% to satisfy regulators.

Pharmaniaga has standing orders of about RM800 million, with about 60% of its business coming from the public sector.  The company also plans to spend about RM40 million in capital expenditures this year, including beginning the process of halal-certification at its manufacturing plants.  Profits in 2009 were about RM81 million, but dropped to RM45 million in 2010.

 

 

Do you like this post?
  • Fascinated
  • Happy
  • Sad
  • Angry
  • Bored
  • Afraid

Reading Time: 1 minute

Executives at Malaysian pharmaceutical company Pharmaniaga say that the company is set to make up 10% of its majority stakeholder’s business in 2011, and 15% of business within the next five years.  Boustead Group owns approximately 97% of the company, but is looking to reduce its contribution to about 75% to satisfy regulators.

Reading Time: 1 minute

Executives at Malaysian pharmaceutical company Pharmaniaga say that the company is set to make up 10% of its majority stakeholder’s business in 2011, and 15% of business within the next five years.  Boustead Group owns approximately 97% of the company, but is looking to reduce its contribution to about 75% to satisfy regulators.

Pharmaniaga has standing orders of about RM800 million, with about 60% of its business coming from the public sector.  The company also plans to spend about RM40 million in capital expenditures this year, including beginning the process of halal-certification at its manufacturing plants.  Profits in 2009 were about RM81 million, but dropped to RM45 million in 2010.

 

 

Do you like this post?
  • Fascinated
  • Happy
  • Sad
  • Angry
  • Bored
  • Afraid